Form 8-K - Current report
SEC Accession No. 0001213900-26-099524
Filing Date
2026-09-14
Accepted
2026-09-14 10:39:02
Documents
14
Period of Report
2026-09-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0305157-8k_onconetix.htm   iXBRL 8-K 30466
2 FORM OF GRID PROMISSORY NOTE, DATED SEPTEMBER 11, 2026, BY AND BETWEEN REALBOTIX ea030515701ex10-1.htm EX-10.1 64116
3 FORM OF GUARANTY OF PAYMENT, DATED SEPTEMBER 11, 2026, BY REALBOTIX CORP. IN FAV ea030515701ex10-2.htm EX-10.2 39091
4 PRESS RELEASE, DATED SEPTEMBER 14, 2026 ea030515701ex99-1.htm EX-99.1 17672
  Complete submission text file 0001213900-26-099524.txt   350767

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE onco-20260911.xsd EX-101.SCH 3017
6 XBRL LABEL FILE onco-20260911_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE onco-20260911_pre.xml EX-101.PRE 22360
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0305157-8k_onconetix_htm.xml XML 3322
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41294 | Film No.: 261376226
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)